nAmbition GmbH (Germany) - Dec 2007

Dresden Fonds GmbH, jointly managed by CFH GmbH and SIB GmbH, has sold all stakes in nAmbition GmbH to strategic investor JPK Instruments AG, for an undisclosed amount. Dresden Fonds realised a larger double-digit IRR with the sale.

Since the strategic investor had been involved in the company from the beginning of financing, selling Dresden Fonds’ minority stake to the investor had always been a likely but not compulsory exit. The acquirer plans to realise strong synergy potential in terms of marketing and distribution, and nAmbition’s products complement JPK Instrument’s own product portfolio, increasing JPK’s competency in the field of molecular analysis. nAmbition is headquartered in Dresden, was founded in 2004 and employs 12 people.

Previous funding

nAmbition received a total of €5m in early-stage financing from both Dresden Fonds GmbH and JPK Instruments AG in August 2005 during a capital increase. During this first and only financing round, Dresden Fonds GmbH acquired a minority stake in the company, and the strategic investor JPK Instruments acquired a minority stake of less than 50%. The deal was sourced through the investor’s network. Nanotechnology company JPK Instruments AG was founded in 1999 and received venture capital from IBB Beteiligungsgesellschaft mbH.

Advisers

Equity - PetersenGründel, Mirko Gründel (Legal)Purchaser - CMS Hasche Sigle, Ralf Kurney (Legal)

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Exits
• Healthcare
• Germany
• Trade sale